• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改善Ⅲb期轻链型心脏淀粉样变性患者的预后评估:血流动力学参数的作用

Improving prognostic evaluations in patients with stage IIIb light chain cardiac amyloidosis: role of haemodynamic parameters.

作者信息

Li Jingyi, Lu Yang, Xu Xiqi, Tian Zhuang, Li Jian, Zhang Shuyang

机构信息

Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing, 100730, China.

Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing, 100730, China.

出版信息

Orphanet J Rare Dis. 2025 Jan 13;20(1):19. doi: 10.1186/s13023-024-03451-z.

DOI:10.1186/s13023-024-03451-z
PMID:39806404
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11727539/
Abstract

BACKGROUND

There is no unified prognostic scoring system for light chain cardiac amyloidosis (AL-CA), particularly stage IIIb AL-CA. This study aimed to use invasive haemodynamic information to investigate markers that can more accurately evaluate the prognosis of patients with stage IIIb AL-CA.

METHODS

In this retrospective cohort study, we conducted invasive haemodynamic measurements concurrently with myocardial biopsies to diagnose AL-CA. We used Cox regression analysis and time-dependent receiver operating characteristic curve analysis to study the associations between these measurements and overall mortality. Echocardiographic parameters were also recorded and analysed via logistic regression to explore their relationships with haemodynamic changes.

RESULTS

Although traditional haemodynamic parameters, such as the cardiac index (CI), pulmonary artery wedge pressure (PAWP), pulmonary artery pressure, and vascular resistance, did not correlate with mortality, the PAWP/CI ratio emerged as a vital prognostic marker. Patients with a PAWP/CI ratio above 11 mmHg/L/min/m had markedly poorer survival. Kaplan‒Meier analysis highlighted the prognostic significance of the ratio, revealing distinct survival differences. Furthermore, logistic regression confirmed that echocardiographically measured pulmonary artery systolic pressure independently correlated with increases in the PAWP/CI ratio.

CONCLUSIONS

In stage IIIb AL-CA patients, the PAWP/CI ratio, which surpasses traditional haemodynamic indicators, significantly predicts all-cause mortality, emphasizing its prognostic value. Our findings suggest that echocardiography-derived PASP could alternatively reflect the PAWP/CI ratio.

摘要

背景

轻链型心脏淀粉样变(AL-CA),尤其是Ⅲb期AL-CA,目前尚无统一的预后评分系统。本研究旨在利用有创血流动力学信息,探究能够更准确评估Ⅲb期AL-CA患者预后的标志物。

方法

在这项回顾性队列研究中,我们在进行心肌活检以诊断AL-CA的同时进行了有创血流动力学测量。我们使用Cox回归分析和时间依赖性受试者工作特征曲线分析,研究这些测量值与总死亡率之间的关联。还记录了超声心动图参数,并通过逻辑回归进行分析,以探讨它们与血流动力学变化的关系。

结果

尽管传统的血流动力学参数,如心脏指数(CI)、肺动脉楔压(PAWP)、肺动脉压和血管阻力,与死亡率无关,但PAWP/CI比值成为一个重要的预后标志物。PAWP/CI比值高于11 mmHg/L/min/m的患者生存率明显较差。Kaplan-Meier分析突出了该比值的预后意义,显示出明显的生存差异。此外,逻辑回归证实,超声心动图测量的肺动脉收缩压与PAWP/CI比值的升高独立相关。

结论

在Ⅲb期AL-CA患者中,PAWP/CI比值超越了传统的血流动力学指标,能显著预测全因死亡率,强调了其预后价值。我们的研究结果表明,超声心动图得出的肺动脉收缩压(PASP)可替代反映PAWP/CI比值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d7/11727539/85ce775740de/13023_2024_3451_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d7/11727539/a4f90cdc0bab/13023_2024_3451_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d7/11727539/85ce775740de/13023_2024_3451_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d7/11727539/a4f90cdc0bab/13023_2024_3451_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d7/11727539/85ce775740de/13023_2024_3451_Fig2_HTML.jpg

相似文献

1
Improving prognostic evaluations in patients with stage IIIb light chain cardiac amyloidosis: role of haemodynamic parameters.改善Ⅲb期轻链型心脏淀粉样变性患者的预后评估:血流动力学参数的作用
Orphanet J Rare Dis. 2025 Jan 13;20(1):19. doi: 10.1186/s13023-024-03451-z.
2
Association between the TAPSE to PASP ratio and short-term outcome in patients with light-chain cardiac amyloidosis.TAPSE 与 PASP 比值与轻链心脏淀粉样变患者短期预后的关系。
Int J Cardiol. 2023 Sep 15;387:131108. doi: 10.1016/j.ijcard.2023.05.058. Epub 2023 Jun 10.
3
Defining echocardiographic predictors of outcome in cardiac amyloidosis by subtype.根据亚型定义心脏淀粉样变的超声心动图预后预测因子。
Curr Probl Cardiol. 2024 Sep;49(9):102729. doi: 10.1016/j.cpcardiol.2024.102729. Epub 2024 Jun 29.
4
Left atrioventricular coupling index assessed with three-dimensional echocardiography: a prognostic marker of short-term outcomes in light-chain cardiac amyloidosis.三维超声心动图评估的左房室耦合指数:轻链型心脏淀粉样变性短期预后的预测指标
Amyloid. 2025 Mar;32(1):63-71. doi: 10.1080/13506129.2024.2448435. Epub 2025 Jan 15.
5
The prognostic value of CMR diastolic parameters in patients with cardiac light-chain amyloidosis: a retrospective analysis.心脏轻链淀粉样变患者中CMR舒张参数的预后价值:一项回顾性分析。
Int J Cardiovasc Imaging. 2025 Mar;41(3):579-589. doi: 10.1007/s10554-025-03347-4. Epub 2025 Feb 14.
6
Diagnostic and prognostic value of the left atrial myopathy evaluation in cardiac amyloidosis using echocardiography.超声心动图评估左心房心肌病在心脏淀粉样变性中的诊断和预后价值
ESC Heart Fail. 2024 Dec;11(6):4139-4147. doi: 10.1002/ehf2.15013. Epub 2024 Aug 11.
7
Associations of Electrocardiographic Parameters with Left Ventricular Longitudinal Strain and Prognosis in Cardiac Light Chain Amyloidosis.心电图参数与心脏轻链淀粉样变性患者左心室纵向应变及预后的相关性。
Sci Rep. 2019 May 23;9(1):7746. doi: 10.1038/s41598-019-44245-9.
8
Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System.二维斑点追踪超声心动图对左心室射血分数保留型轻链型淀粉样变性患者预后的评估:对现行预后分期系统的补充价值。
JACC Cardiovasc Imaging. 2017 Apr;10(4):398-407. doi: 10.1016/j.jcmg.2016.04.008. Epub 2016 Sep 14.
9
Prognosis of light chain amyloidosis: a multivariable analysis for survival prediction in patients with cardiac involvement proven by endomyocardial biopsy.轻链淀粉样变的预后:通过心内膜心肌活检证实心脏受累的患者的生存预测的多变量分析。
Open Heart. 2023 Jul;10(2). doi: 10.1136/openhrt-2023-002310.
10
Pulmonary Transit Time Derived from First-Pass Perfusion Cardiac MR Imaging: A Potential New Marker for Cardiac Involvement and Prognosis in Light-Chain Amyloidosis.基于首过灌注心脏 MRI 的肺通过时间:轻链淀粉样变中心脏受累和预后的一个潜在新标志物。
J Magn Reson Imaging. 2024 Sep;60(3):999-1010. doi: 10.1002/jmri.29135. Epub 2023 Nov 16.

引用本文的文献

1
The Prognostic Value of Platelet-to-Lymphocyte Ratio and Tricuspid Regurgitation Velocity in Patients with Light-Chain Myocardial Amyloidosis.血小板与淋巴细胞比值及三尖瓣反流速度在轻链型心肌淀粉样变患者中的预后价值
J Inflamm Res. 2025 Jul 3;18:8787-8804. doi: 10.2147/JIR.S520998. eCollection 2025.

本文引用的文献

1
Reduced early mortality with Daratumumab-based frontline therapy in AL amyloidosis: A retrospective cohort study.达雷妥尤单抗一线治疗降低 AL 型淀粉样变性早期死亡率:一项回顾性队列研究
Am J Hematol. 2024 Mar;99(3):477-479. doi: 10.1002/ajh.27179. Epub 2023 Dec 15.
2
Daratumumab in first-line treatment of patients with light chain amyloidosis and Mayo stage IIIb improves treatment response and overall survival.达雷妥尤单抗一线治疗轻链淀粉样变性且 Mayo 分期为 IIIb 的患者可改善治疗反应和总生存期。
Haematologica. 2024 Jan 1;109(1):220-230. doi: 10.3324/haematol.2023.283325.
3
Hemodynamic Profiling and Prognosis in Cardiac Amyloidosis.
心脏淀粉样变性的血流动力学分析与预后
Circ Heart Fail. 2023 Mar;16(3):e010078. doi: 10.1161/CIRCHEARTFAILURE.122.010078. Epub 2023 Jan 25.
4
The challenge of managing patients with light-chain cardiac amyloidosis: the value of cardiac magnetic resonance as a guide to the treatment response.管理轻链型心脏淀粉样变性患者的挑战:心脏磁共振作为治疗反应指导的价值。
Eur Heart J. 2022 Dec 1;43(45):4736-4738. doi: 10.1093/eurheartj/ehac526.
5
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.2022年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南。
Eur Heart J. 2022 Oct 11;43(38):3618-3731. doi: 10.1093/eurheartj/ehac237.
6
Prognostic Utility of Echocardiographic Atrial and Ventricular Strain Imaging in Patients With Cardiac Amyloidosis.超声心动图心房和心室应变成像在心脏淀粉样变性患者中的预后价值。
JACC Cardiovasc Imaging. 2021 Aug;14(8):1508-1519. doi: 10.1016/j.jcmg.2021.01.016. Epub 2021 Mar 17.
7
Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.心脏淀粉样变:被忽视、被低估且可治疗。
Annu Rev Med. 2020 Jan 27;71:203-219. doi: 10.1146/annurev-med-052918-020140.
8
Incidence of AL Amyloidosis in Olmsted County, Minnesota, 1990 through 2015.明尼苏达州奥姆斯特德县 1990 年至 2015 年 AL 淀粉样变性的发病率。
Mayo Clin Proc. 2019 Mar;94(3):465-471. doi: 10.1016/j.mayocp.2018.08.041. Epub 2019 Jan 31.
9
Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of Echocardiography.成人经胸超声心动图全面检查操作指南:美国超声心动图学会的建议
J Am Soc Echocardiogr. 2019 Jan;32(1):1-64. doi: 10.1016/j.echo.2018.06.004. Epub 2018 Oct 1.
10
Pathophysiology and treatment of pulmonary hypertension in sickle cell disease.镰状细胞病中肺动脉高压的病理生理学与治疗
Blood. 2016 Feb 18;127(7):820-8. doi: 10.1182/blood-2015-08-618561. Epub 2016 Jan 12.